C330006A16Rik Inhibitors
The target protein, C330006A16Rik, plays a pivotal role in cellular signaling, participating in pathways crucial for growth, survival, and differentiation. Functionally, it is intricately involved in the MAPK, Wnt, PI3K/Akt/mTOR, and other signaling cascades, orchestrating cellular responses to maintain homeostasis. Inhibition of C330006A16Rik involves targeted modulation of these pathways, where various chemicals act upon specific components. MEK inhibitors like PD98059 and Trametinib disrupt the MAPK pathway, impacting downstream effectors and altering cellular responses associated with proliferation and survival. GSK-3 inhibitor SB216763 indirectly influences C330006A16Rik by modulating the Wnt pathway, affecting downstream events crucial for growth and differentiation.
PI3K inhibitors such as Wortmannin and LY294002 impede the PI3K/Akt/mTOR pathway, influencing cellular survival and proliferation. mTOR inhibitor Rapamycin disrupts mTORC1, impacting downstream cellular responses. PKC inhibitor Sotrastaurin modulates PKC-associated pathways, influencing events related to proliferation and survival. In summary, the inhibition of C330006A16Rik involves intricate modulation of specific signaling pathways, illustrating the complexity of chemical interactions within the cellular milieu. Understanding these interactions is essential for devising effective strategies to modulate C330006A16Rik expression and function for potential applications in cellular research and beyond.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
AMP-activated protein kinase (AMPK) activator. Indirectly inhibits C330006A16Rik by activating AMPK, leading to downstream effects on cellular energy metabolism and growth pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK1/2 inhibitor blocking the MAPK pathway. Indirectly impacts C330006A16Rik by interfering with MAPK signaling, influencing downstream cellular responses related to proliferation and survival. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
GSK-3 inhibitor regulating Wnt signaling. Indirectly influences C330006A16Rik by modulating the Wnt pathway, impacting downstream events crucial for cellular processes associated with growth and differentiation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor suppressing c-Jun N-terminal kinase activity. Modulates AP-1 transcription factor and downstream targets. Indirectly affects C330006A16Rik by altering JNK-associated signaling pathways, influencing cellular responses. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor blocking PI3K/Akt signaling. Suppresses cell survival and proliferation. Indirectly influences C330006A16Rik by impacting the PI3K pathway and its associated cellular responses. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor disrupting mTORC1 complex. Suppresses protein synthesis and cell growth. Indirectly affects C330006A16Rik by influencing mTOR-associated pathways, altering downstream cellular responses. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
MEK1/2 inhibitor targeting the MAPK pathway. Suppresses cell growth and induces apoptosis. Indirectly influences C330006A16Rik by interfering with the MAPK signaling cascade, impacting downstream cellular events. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor impeding PI3K/Akt/mTOR signaling. Suppresses cell survival and proliferation. Indirectly affects C330006A16Rik through the PI3K pathway, influencing downstream cellular responses associated with growth and survival. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor impeding p38 signaling. Modulates transcription factors and cytokine production. Indirectly impacts C330006A16Rik by interfering with the p38 MAPK pathway, altering downstream cellular responses associated with proliferation. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $182.00 $332.00 | 67 | |
Akt inhibitor blocking Akt signaling. Suppresses cell survival and proliferation. Indirectly influences C330006A16Rik through the Akt pathway, impacting downstream cellular responses associated with growth and survival. | ||||||